0
Article |

EFFECT OF FEEDING A LIPOTROPIC SUBSTANCE TO PATIENTS WITH XANTHELASMA

ARTHUR C. CURTIS, M.D.; JOHN P. BERGER, M.D.
Arch Derm Syphilol. 1945;52(4):252-256. doi:10.1001/archderm.1945.01510280036008.
Text Size: A A A
Published online

The association of hyperlipemia with xanthelasma is well known and has been the subject of study by several investigators.1 The relation which the hyperlipemia has to cardiovascular disease, especially peripheral and coronary arteriosclerosis, is less well recognized but likewise has been found to be rather common.1 From such observations, it would seem that the presence of these benign fatty lesions within the skin of the eyelids may suggest a disturbance in fat metabolism, in some persons severe enough to warrant further study in regard to the blood lipids, cardiac function and peripheral vascular sufficiency.

If xanthelasma may at times be the herald lesions of disturbed fat metabolism, it then should be determined whether some of the lipotropic substances which have so pronounced an effect on several types of experimental and acquired disturbances in fat storage and metabolism might not be of value in lowering the blood

Topics

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 8

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs